RPRX Annual FCF
$2.99 B
+$843.82 M+39.36%
31 December 2023
Summary:
As of January 22, 2025, RPRX annual free cash flow is $2.99 billion, with the most recent change of +$843.82 million (+39.36%) on December 31, 2023. During the last 3 years, it has risen by +$953.17 million (+46.85%). RPRX annual FCF is now at all-time high.RPRX Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Quarterly FCF
$703.61 M
+$45.41 M+6.90%
30 September 2024
Summary:
As of January 22, 2025, RPRX quarterly free cash flow is $703.61 million, with the most recent change of +$45.41 million (+6.90%) on September 30, 2024. Over the past year, it has increased by +$38.98 million (+5.86%). RPRX quarterly FCF is now -57.80% below its all-time high of $1.67 billion, reached on December 31, 2019.RPRX Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX TTM FCF
$2.80 B
+$130.09 M+4.87%
30 September 2024
Summary:
As of January 22, 2025, RPRX TTM free cash flow is $2.80 billion, with the most recent change of +$130.09 million (+4.87%) on September 30, 2024. Over the past year, it has increased by +$180.49 million (+6.89%). RPRX TTM FCF is now -10.75% below its all-time high of $3.14 billion, reached on September 30, 2020.RPRX TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
RPRX Free Cash Flow Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +39.4% | +5.9% | +6.9% |
| 3 y3 years | +46.9% | +5.9% | +6.9% |
| 5 y5 years | +84.6% | +191.4% | +67.9% |
RPRX Free Cash Flow High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.1% | -31.9% | +52.9% | -6.3% | +43.4% |
| 5 y | 5-year | at high | +79.2% | -57.8% | +52.9% | -10.8% | +67.9% |
| alltime | all time | at high | +110.7% | -57.8% | +191.4% | -10.8% |
Royalty Pharma Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $703.61 M(+6.9%) | $2.80 B(+4.9%) |
| June 2024 | - | $658.21 M(-1.0%) | $2.67 B(+1.9%) |
| Mar 2024 | - | $664.64 M(-14.0%) | $2.62 B(-12.4%) |
| Dec 2023 | $2.99 B(+39.4%) | $772.63 M(+34.7%) | $2.99 B(+7.3%) |
| Sept 2023 | - | $573.52 M(-5.6%) | $2.79 B(+1.3%) |
| June 2023 | - | $607.82 M(-41.2%) | $2.75 B(+1.2%) |
| Mar 2023 | - | $1.03 B(+81.4%) | $2.72 B(+26.8%) |
| Dec 2022 | $2.14 B(+6.3%) | $569.93 M(+5.8%) | $2.14 B(+3.9%) |
| Sept 2022 | - | $538.83 M(-6.3%) | $2.06 B(+3.5%) |
| June 2022 | - | $574.95 M(+24.9%) | $1.99 B(+2.2%) |
| Mar 2022 | - | $460.27 M(-6.1%) | $1.95 B(-3.3%) |
| Dec 2021 | $2.02 B | $489.96 M(+4.3%) | $2.02 B(-3.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2021 | - | $469.76 M(-11.7%) | $2.09 B(-1.8%) |
| June 2021 | - | $531.72 M(+1.1%) | $2.13 B(+2.0%) |
| Mar 2021 | - | $526.10 M(-7.0%) | $2.09 B(+2.7%) |
| Dec 2020 | $2.03 B(+22.0%) | $565.67 M(+11.2%) | $2.03 B(-35.1%) |
| Sept 2020 | - | $508.85 M(+4.1%) | $3.14 B(+68.8%) |
| June 2020 | - | $489.00 M(+3.8%) | $1.86 B(+8.9%) |
| Mar 2020 | - | $471.10 M(-71.7%) | $1.71 B(+2.3%) |
| Dec 2019 | $1.67 B(+3.0%) | $1.67 B(-316.6%) | $1.67 B(>+9900.0%) |
| Sept 2019 | - | -$769.78 M(-328.6%) | $0.00(-100.0%) |
| June 2019 | - | $336.79 M(-22.2%) | $769.78 M(+77.8%) |
| Mar 2019 | - | $432.99 M | $432.99 M |
| Dec 2018 | $1.62 B(+14.1%) | - | - |
| Dec 2017 | $1.42 B | - | - |
FAQ
- What is Royalty Pharma annual free cash flow?
- What is the all time high annual FCF for Royalty Pharma?
- What is Royalty Pharma annual FCF year-on-year change?
- What is Royalty Pharma quarterly free cash flow?
- What is the all time high quarterly FCF for Royalty Pharma?
- What is Royalty Pharma quarterly FCF year-on-year change?
- What is Royalty Pharma TTM free cash flow?
- What is the all time high TTM FCF for Royalty Pharma?
- What is Royalty Pharma TTM FCF year-on-year change?
What is Royalty Pharma annual free cash flow?
The current annual FCF of RPRX is $2.99 B
What is the all time high annual FCF for Royalty Pharma?
Royalty Pharma all-time high annual free cash flow is $2.99 B
What is Royalty Pharma annual FCF year-on-year change?
Over the past year, RPRX annual free cash flow has changed by +$843.82 M (+39.36%)
What is Royalty Pharma quarterly free cash flow?
The current quarterly FCF of RPRX is $703.61 M
What is the all time high quarterly FCF for Royalty Pharma?
Royalty Pharma all-time high quarterly free cash flow is $1.67 B
What is Royalty Pharma quarterly FCF year-on-year change?
Over the past year, RPRX quarterly free cash flow has changed by +$38.98 M (+5.86%)
What is Royalty Pharma TTM free cash flow?
The current TTM FCF of RPRX is $2.80 B
What is the all time high TTM FCF for Royalty Pharma?
Royalty Pharma all-time high TTM free cash flow is $3.14 B
What is Royalty Pharma TTM FCF year-on-year change?
Over the past year, RPRX TTM free cash flow has changed by +$180.49 M (+6.89%)